Foghorn Therapeutics Inc. (FHTX)
NASDAQ·Healthcare·Biotechnology
$5.16
-0.96%
Mkt Cap $311.70M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 11, 2026 | $10.15M | $9.25M | -8.91% | -$0.28 | -$0.34 | -21.43% | — | — |
| Q4 2025 Nov 5, 2025 | $9.50M | $8.15M | -14.18% | -$0.31 | -$0.25 | +19.35% | — | — |
| Q3 2025 Aug 5, 2025 | $8.17M | $7.56M | -7.54% | -$0.31 | -$0.28 | +9.68% | — | — |
| Q2 2025 May 14, 2025 | $6.24M | $5.95M | -4.61% | -$0.30 | -$0.30 | +0.00% | — | — |
| Q1 2025 Mar 6, 2025 | $8.67M | $2.86M | -67.06% | -$0.43 | -$0.30 | +30.23% | — | — |
| Q4 2024 Nov 4, 2024 | $8.14M | $7.81M | -4.03% | -$0.42 | -$0.31 | +26.19% | — | — |
| Q3 2024 Aug 8, 2024 | $6.04M | $6.89M | +14.04% | -$0.60 | -$0.45 | +25.00% | — | — |
| Q2 2024 May 6, 2024 | $6.91M | $5.05M | -26.92% | -$0.55 | -$0.59 | -7.27% | — | — |
| Q1 2024 Mar 7, 2024 | $4.62M | $5.77M | +24.87% | -$0.79 | -$0.57 | +27.85% | — | — |
| Q4 2023 Nov 2, 2023 | $4.62M | $17.48M | +278.31% | -$0.72 | -$0.34 | +52.78% | — | — |
| Q3 2023 Aug 4, 2023 | $6.26M | $5.60M | -10.56% | -$0.73 | -$0.70 | +4.11% | — | — |
| Q2 2023 May 8, 2023 | $6.26M | $5.31M | -15.19% | -$0.68 | -$0.73 | -7.35% | — | — |
| Q1 2023 Mar 9, 2023 | $5.04M | $4.18M | -16.98% | -$0.59 | -$0.69 | -16.95% | — | — |
| Q4 2022 Nov 8, 2022 | $8.48M | $6.63M | -21.77% | -$0.60 | -$0.62 | -3.33% | — | — |
| Q3 2022 Aug 9, 2022 | $9.58M | $4.49M | -53.15% | -$0.53 | -$0.66 | -24.53% | — | — |
| Q2 2022 May 9, 2022 | $9.43M | $3.92M | -58.43% | -$0.40 | -$0.65 | -62.50% | — | — |
| Q1 2022 Mar 10, 2022 | $709.75K | $713.00K | +0.46% | -$0.74 | -$0.77 | -4.05% | — | — |
| Q4 2021 Nov 9, 2021 | $250.00K | $41.00K | -83.60% | -$0.66 | -$0.71 | -7.58% | — | — |
| Q3 2021 Aug 10, 2021 | $279.00K | $279.00K | +0.00% | -$0.63 | -$0.63 | +0.00% | — | — |
| Q2 2021 May 11, 2021 | $290.54K | $286.00K | -1.56% | -$0.63 | -$0.62 | +1.59% | — | — |